AVIVA ZOHAR: Open Payments
NPI 1710109608 · NARBERTH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 17 payments from 7 companies in 2025. Trend: 2023 $734 · 2024 $549 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $188 |
| ABBVIE INC. | 5 | $88 |
| Braeburn Inc. | 3 | $62 |
| Bausch Health US, LLC | 2 | $49 |
| Indivior Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: Auvelity, VRAYLAR, BRIXADI, WELLBUTRIN, SUBLOCADE, INGREZZA, CAPLYTA.
Industry payments across PA — which companies pay providers there.
